EVGN
Evogene Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.37
−4.71%3
Insider buys (3m)
0
Insider sells (3m)
$692.8K
Net value (3m)
-33.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 30, 2026 | RECANATI LEON · director | A-Award | 2,500 | $0.58 |
| Sep 30, 2026 | Nimrodi Nir · director | A-Award | 10,000 | $0.58 |
| Sep 30, 2026 | Percy Adrian John · director | A-Award | 2,500 | $0.58 |
| Sep 30, 2026 | Falk Dan Michael · director | A-Award | 2,500 | $0.58 |
| Aug 26, 2026 | Tarcic Gabi · officer: Chief Development Officer | Purchase | 1,129 | $0.60 |
| Aug 13, 2026 | RECANATI LEON · director | Purchase | 460,000 | $0.64 |
| Aug 5, 2026 | RECANATI LEON · director | Purchase | 800,000 | $0.50 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 30, 2026